Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... % of the patients in 2011 and 29% in 2014 (p>0.05) and a control of lipid metabolism was absent in 12% and 14 ..."
 
Vol 9, No 2 (2013) MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina
"... Aim. To assess the quality of lipid-lowering therapy in high risk patients with cardiovascular ..."
 
Vol 12, No 6 (2016) THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 Abstract  PDF (Eng)  PDF (Eng)  similar documents
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov
"... lipid-lowering agents were used only in rare cases. From 2011 to 2015 the proportion of patients taking ..."
 
Vol 12, No 3 (2016) EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY Abstract  PDF (Eng)  similar documents
E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz
"... cover issues of efficacy and safety of lipid-lowering therapy in primary and secondary prevention ..."
 
Vol 11, No 5 (2015) Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis Abstract  similar documents
N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov
"... Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients ..."
 
Vol 6, No 1 (2010) EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS Abstract  PDF (Eng)  similar documents
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova
"... in patients with IHD after cardiovascular events. Lipid-lowering therapy is conducted inefficiently ..."
 
Vol 11, No 1 (2015) ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE Abstract  similar documents
M. V. Solodun, S. S. Yakushin
"... . All patients were prescribed atorvastatin. A group of 65 people in whom lipid levels were studied ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... .3% and a specificity of 90%. Conclusion. Intensive lipid-lowering therapy in patients with a very high cardiovascular ..."
 
Vol 14, No 5 (2018) Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation Abstract  similar documents
Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov
"... Aim. To assess the economic burden associated with the absence of lipid-lowering therapy (LLT ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... ; p<0.001) after 6 months was found in patients treated with lipid-lowering therapy in combination ..."
 
Vol 17, No 2 (2021) The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... and rosuvastatin is an effective drug that allows achieving not only adequate hypotensive and lipid-lowering ..."
 
Vol 12, No 2 (2016) LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta
"... Aim. To study the features of lipid-lowering therapy with rosuvastatin in high and very high ..."
 
Vol 17, No 6 (2021) Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident Abstract  similar documents
S. A. Boytsov, M. A. Piradov, M. M. Tanashyan, I. A. Voznjouk, M. V. Ezhov, E. V. Oschepkova, I. V. Sergienko, N. A. Shamalov, S. N. Yanishevskiy
"... of atherothrombotic genesis, namely lipid metabolism disorders, the modern evidence base for lipid-lowering therapy ..."
 
Vol 14, No 3 (2018) HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE Abstract  similar documents
O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta
"... . The issues of lipid-lowering therapy with statins in the aspect of stroke prevention are discussed ..."
 
Vol 20, No 4 (2024) Increased lipoprotein (a) as an additional factor in the failure to achieve target blood pressure levels and lipid spectrum optimal parameters in patients with arterial hypertension and multifocal atherosclerosis Abstract  similar documents
S. S. Vedenskaya, O. G. Smolenskaya
"... received antihypertensive, lipid-lowering, and antiplatelet therapy. Results. Patients in groups 1 and 2 ..."
 
Vol 17, No 1 (2021) Lipid Clinic is an Efficacious Model of Preventive Medicine Abstract  PDF (Eng)  similar documents
A. V. Blokhina, A. I. Ershova, A. N. Meshkov, A. S. Limonova, V. I. Mikhailina, O. M. Drapkina
"... statin therapy was recommended for 32% of patients, and combined lipid-lowering therapy – for 14 ..."
 
Vol 14, No 1 (2018) IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION Abstract  similar documents
I. V. Sergienko, A. A. Ansheles
"... treated with lipid-lowering drugs. Patients with lipid-lowering therapy had significantly higher values ..."
 
Vol 14, No 6 (2018) The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial Abstract  PDF (Eng)  similar documents
Yu. A. Karpov
"... and discuss the clinical perspective of these data. Patients with acute coronary syndrome are at very high ..."
 
Vol 19, No 6 (2023) New possibilities for lipid level control using inclisiran — prospects for interaction between a cardiologist and a neurologist Abstract  similar documents
A. B. Skiba, M. V. Menzorov, V. D. Puchek, I. M. Buchin, I. I. Polyakov, E. N. Menzorova
"... of combination lipid-lowering therapy for secondary prevention in patients at very high cardiovascular risk ..."
 
Vol 8, No 5 (2012) LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS Abstract  similar documents
A. N. Meshkov
"... Assessment of lipid-lowering effect of rosuvastatin is presented, as well as the main results ..."
 
Vol 2, No 3 (2006) EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
A. V. Shabalin, Yu. I. Ragino, S. A. Lyubimtseva, Ya. V. Polonskaya, M. V. Ivanova
"... . Mildronate did not have any effect on the blood lipid profile in elderly patients with IHD. The initial level ..."
 
Vol 20, No 6 (2024) The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) Abstract  similar documents
K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev
"... strategy in increasing the frequency of low-density lipoprotein cholesterol (LDL-С) monitoring in patients ..."
 
Vol 19, No 2 (2023) Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) Abstract  similar documents
M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov
"... Aim. To study the frequency of prescriptions of various types of lipid-lowering therapy ..."
 
Vol 11, No 5 (2015) Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation Abstract  similar documents
E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
"... <0.05) were observed. A number of patients with achieved target levels of all studied lipid ..."
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
"... Review of large of trials that prove the positive impact of high-dose lipid-lowering therapy ..."
 
Vol 1, No 2 (2005) ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov
"... patients quality of life (p<0,05). Spirapril didn’t change lipid and glucose metabolism, regardless ..."
 
Vol 17, No 2 (2021) Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care Abstract  PDF (Eng)  similar documents
S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova
"... .0 and 87.8%; p>0.05). Adherent patients had lower mean values of lipids: total cholesterol (4.7±1.2 vs 5 ..."
 
Vol 17, No 6 (2021) PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center Abstract  similar documents
A. V. Blokhina, A. I. Ershova, A. S. Limonova, O. V. Kopylova, A. N. Meshkov, O. M. Drapkina
"... records of patients who visited the Lipid clinic of the National Medical Research Center for Therapy ..."
 
Vol 3, No 3 (2007) THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova
"... , but LDL-C level significantly reduced (from 3.06±1.32 to 2.7±1.0 mmol/l, p<0.05) in IHD patients after 3 ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... . Examination of patients with STEMI included the assessment of plasma lipid profile, blood levels of hepatic ..."
 
Vol 9, No 5 (2013) ASSESSING FACTORS THAT FORM PATIENT’S ATTITUDE TO TREATMENT PRECEDING HOSPITALIZATION FOR ACUTE CORONARY SYNDROM (DATA OF QUESTIONNAIRE WITHIN THE LIS REGISTER) Abstract  PDF (Eng)  similar documents
Yu. V. Lukina, M. L. Gynzburg, V. P. Smirnov, S. Yu. Martsevich, N. P. Kutishenko, A. V. Fokina, E. V. Daniels
"... and methods. A register of patients admitted to Lyubertsy Regional Hospital №2 for ACS from 01.12.2011 to 01 ..."
 
Vol 18, No 3 (2022) Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER Abstract  similar documents
I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk
"... Aim. To study the dynamics of the lipid profile of hypertensive patients with dyslipidemia who ..."
 
Vol 16, No 5 (2020) Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov
"... , it was found that 100% of patients in 2011-2012 years and 98.2% in 2016-2017 years had indications ..."
 
Vol 9, No 4 (2013) REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy
"... from May, 1st till December, 31st, 2011 were divided into 3 groups: a control group (82 patients who ..."
 
Vol 11, No 1 (2015) HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE Abstract  similar documents
S. V. Shalaev, L. V. Silicic, O. V. Abaturova
"... Aspects of heart rate-lowering therapy in patients with chronic heart failure using If-channel ..."
 
Vol 11, No 1 (2015) CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. Yu. Suvorov, M. L. Ginzburg, A. D. Deev, S. A. Boytsov, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina
"... 72.9±9.8 years). Low frequency of the antihypertensive therapy (34.5%), lipid-lowering therapy (0 ..."
 
Vol 5, No 5 (2009) ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS Abstract  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina
"... Aim. To evaluate factors affecting hypoglycemic therapy in patients with type 2 diabetes mellitus ..."
 
Vol 16, No 2 (2020) Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries Abstract  similar documents
O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich
"... ) in young patients. Material and methods. The study design is based on a comparison of observation data ..."
 
Vol 20, No 2 (2024) Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina
"... group and 7 (15.2%) patients from the placebo group took constant lipid- lowering therapy. The patients ..."
 
Vol 13, No 4 (2017) USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA Abstract  similar documents
O. M. Drapkina, A. S. Lishuta
"... measurements, lipid levels were taken from the patient's medical records. The safety assessment was also ..."
 
Vol 2, No 2 (2006) THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL Abstract  similar documents
Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto
"... Aim. To evaluate effects of long-term treatment with rilmenidine compared with atenolol on lipid ..."
 
Vol 17, No 3 (2021) Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension Abstract  similar documents
E. V. Kokhan, G. K. Kiyakbaev, E. M. Ozova, V. A. Romanova, Zh. D. Kobalava
"... ) function in hypertensive patients with paroxysmal or persistent mild symptomatic atrial fibrillation ..."
 
Vol 17, No 1 (2021) Existing problems and new possibilities in the treatment of dyslipidemia Joint Conclusion Based on the Results of the Expert Council Abstract  similar documents
M. V. Ezhov, V. V. Kukharchuk, I. V. Sergienko, N. M. Akhmedzhanov, M. I. Voevoda, V. S. Gurevich, V. V. Kashtalap, V. O. Konstantinov, V. V. Skibitsky, I. I. Shaposhnik
"... of the strategy of early combined lipid-lowering therapy for doctors and these categories of patients was held ..."
 
Vol 21, No 1 (2025) Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment Abstract  similar documents
A. M. Namitokov, U. V. Chubykina, V. K. Zafiraki, M. V. Ezhov
"... (FH) diagnosis.    Material and methods. A retrospective cohort study included 45 patients (25 men ..."
 
Vol 14, No 6 (2018) Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation) Abstract  PDF (Eng)  similar documents
L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk
"... -blockers (78.1%), and minimal for lipid-lowering drugs (statins; 61.6%). A significant decrease ..."
 
Vol 16, No 4 (2020) Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues Abstract  similar documents
M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova
"... cholesterol (LDL-C) as the primary target in addressing lipid-lowering therapy. The target level of LDL-C ..."
 
Vol 12, No 6 (2016) State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes Abstract  PDF (Eng)  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... . The fixed combination of enalapril and indapamide in addition to lipid-lowering and hypoglycemic therapy ..."
 
Vol 12, No 1 (2016) State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... . The fixed combination of enalapril and indapamide in addition to lipid-lowering and hypoglycemic therapy ..."
 
Vol 15, No 5 (2019) Association of rs556621 Polymorphism with Development of Stroke in Patients with Cardiovascular Pathology Abstract  similar documents
S. Yu. Nikulina, V. A. Shulman, A. A. Chernova, S. V. Prokopenko, D. A. Nikulin, I. M. Platunova, S. S. Tretyakova, V. N. Maksimov, A. A. Gurazheva
"... lipid-lowering and antithrombotic therapy.  ..."
 
Vol 6, No 1 (2010) PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
E. V. Horolets, L. A. Haisheva, S. V. Shlyk, L. I. Katelnitskaya
"... Aim. To study purine metabolism and lipid peroxidation in patients with acute myocardial ..."
 
Vol 7, No 5 (2011) HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
"... ) in stable ischemic heart disease patients. Material and methods. 264 patients (213 male, age 58.8±1.0 years ..."
 
Vol 10, No 5 (2014) EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova
"... Aim. To study the efficacy of rosuvastatin in dyslipidemia correction in patients after Q-wave ..."
 
Vol 13, No 3 (2017) TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 Abstract  similar documents
O. M. Drapkina, A. S. Luishuta
"... <0.05). This demonstrated an adequate antihypertensive and lipid-lowering effect of the applied ..."
 
Vol 10, No 5 (2014) RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME Abstract  similar documents
N. V. Perova, V. A. Metelskaya
"... of dyslipidemia correction. The use of statins as lipid-lowering therapy in patients with acute coronary syndrome ..."
 
Vol 15, No 5 (2019) Outpatient Register of Patients with Acute Myocardial Infarction: Assessment of the Hypertension Impact on Long-term Prognosis Abstract  similar documents
D. P. Sichinava, E. P. Kalaydzhyan, N. P. Kutishenko, S. Yu. Martsevich
"... .1%), p<0.05. Patients with AH compared with patients without AH were less likely to smoke (18.6% and 38 ..."
 
Vol 9, No 2 (2013) PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET Abstract  similar documents
L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova
"... and parathyroidectomy (p<0.05). BP reduction not requiring antihypertensive drugs dose adjustment was found in patients ..."
 
Vol 13, No 5 (2017) AGE AND GENDER PECULIARITIES OF BLOOD LIPIDS IN URBAN RESIDENTS (CROSS-SECTIONAL STUDY RESULTS) Abstract  similar documents
S. A. Urazgildeeva, M. Yu. Nizhegorodcev, P. S. Sadovnikov, A. Yu. Olkhovik, D. Yu. Nokhrin, M. V. Muzalevskaya, I. V. Shugurova, D. G. Malenkovskaya, A. V. Tregubov, V. S. Gurevich
"... Aim. To analyze the results of measurements of the blood lipid spectrum of urban  residents ..."
 
Vol 3, No 1 (2007) EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
R. M. Zaslavskaya, G. V. Lilitsa, Ye. V. Kalinina, I. A. Komissarova, L. N. Maximova
"... Aim. To study clinical efficacy of a new domestic metabolic drug Eltacine in patients with chronic ..."
 
Vol 16, No 1 (2020) The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion) Abstract  similar documents
M. V. Ezhov, A. Catapano, C. Escobar, V. V. Kukharchuk, M. I. Voevoda, O. M. Drapkina, S. A. Shalnova, A. V. Starodubova, V. S. Gurevich, I. I. Shaposhnik, O. O. Bolshakova, O. S. Oynotkinova, A. S. Alieva
"... with the prospect of lifelong therapy with lipid-lowering drugs. These individuals do not have an indication ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... and target lipid levels achievement. Material and methods. The total of 161 type 2 diabetic patients ..."
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... with hyperlipidemia. Material and methods. Patients (6 men and 24 women) aged 38 to 77 years, which needed in lipid ..."
 
Vol 9, No 1 (2013) ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM Abstract  similar documents
M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachok
"... a number of patients with general asthenia decreased on 70.5% (p<0.05), with physical asthenia — on 47 ..."
 
Vol 5, No 5 (2009) LONG-TERM THERAPY WITH INDAPAMIDE IN ELDERLY AND SENILE PATIENTS WITH HYPERTENSION: CARDIORENOPROTECTIVE EFFECTS AND INFLUENCE ON QUALITY OF LIFE Abstract  similar documents
M. E. Statsenko, T. G. Sherbakova, S. V. Belenkova, O. E. Sporova
"... and senile patients with arterial hypertension (HT) and its influence on quality of life. Material ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 6, No 6 (2010) COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE Abstract  similar documents
S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova
"... lipid-lowering therapy compared with standard therapy is proven in patients with both stable and acute ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... institution for the first time in 2011. Patients were divided into two groups according to their age: younger ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... ) unreasonably overestimated lipid-lowering activity of combination therapy with low doses of statins ..."
 
Vol 17, No 2 (2021) Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options Abstract  similar documents
V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya
"... in patients with multifocal arterial lesions using antihypertensive, antithrombotic and lipid-lowering therapy ..."
 
Vol 14, No 1 (2018) THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA Abstract  PDF (Eng)  similar documents
S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina
"...  Aim. To conduct a comparative study of the changes in blood lipids profiles in populations ..."
 
Vol 17, No 6 (2021) Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia Abstract  similar documents
D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash
"... , hypertension, smoking, alcohol consumption and an increase in the number of respondents taking lipid-lowering ..."
 
Vol 5, No 1 (2009) COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
"... ) in comparison with metoprolol (M) in hypertensive patients with overweight or obesity. Material and methods ..."
 
Vol 10, No 5 (2014) STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE Abstract  similar documents
L. N. Malay
"... and achievements of target lipid levels in real medical practice among population of Russian patients is evaluated ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... -lowering and anti-atherogenic effects of UDCA in patients with NAFLD. This paper  presents a critical ..."
 
Vol 13, No 1 (2017) LIS-3 REGISTER OF THE ACUTE CORONARY SYNDROME: WHAT HAS CHANGED IN A "PORTRAIT" OF A PATIENT AND SHORT-TERM OUTCOMES OF THE DISEASE COMPARED TO LIS-1 REGISTER Abstract  similar documents
S. Yu. Martsevich, Y. V. Semenova, N. P. Kutishenko, M. L. Ginzburg, A. V. Zagrebelnyy, A. V. Fokina, E. V. Daniels
"... Aim. To compare a «portrait» of a patient and hospital lethality between register LIS-1 ..."
 
Vol 5, No 6 (2009) RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE Abstract  similar documents
G. I. Nechaeva, E. N. Loginova
"... ,8±0,8 to 28,9±1,18 kg/m2 (p<0,05), respectively. In patients of the main group systolic and diastolic ..."
 
Vol 7, No 6 (2011) EFFICACY OF CORONARY STENTING AND BASIC PHARMACOTHERAPY IN ELDERLY AND SENILE PATIENTS: THE RESULTS OF LONG-TERM PROSPECTIVE FOLLOW-UP Abstract  similar documents
L. R. Mirzakhanova
"... Aim. To compare survival rate and quality of life in geriatric patients after coronary stenting ..."
 
Vol 18, No 4 (2022) Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders Abstract  PDF (Eng)  similar documents
S. A. Shalnova, V. A. Metelskaya, V. A. Kutsenko, E. B. Yarovaya, A. V. Kapustina, G. A. Muromtseva, G. E. Svinin, Yu. A. Balanova, A. E. Imaeva, S. E. Evstifeeva, V. G. Vilkov, O. L. Barbarash, O. A. Belova, Yu. I. Grinshtein, A. Yu. Efanov, O. N. Kalachikova, N. V. Kulakova, O. P. Rotar, I. A. Trubacheva, D. V. Duplyakov, R. A. Libis, I. A. Viktorova, A. N. Redko, S. S. Yakushin, S. A. Boytsov, E. V. Shlyakhto, O. M. Drapkina
"... in ESSE RF (1) and 3.8 years in ESSE RF(2). Analysis was performed for three lipid variables: total ..."
 
Vol 16, No 1 (2020) Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease Abstract  similar documents
A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko
"... ) and require enhanced lipid-lowering therapy. Material and methods. The study included 49 patients (aged of 61 ..."
 
Vol 13, No 5 (2017) COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES Abstract  similar documents
A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash
"... common in female patients (p<0.05), whereas chronic hepatitis (p=0.079) and urolithiasis – in males (p=0 ..."
 
Vol 11, No 1 (2015) METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... and indapamide on insulin resistance (IR), glucose, lipid and purine metabolism in patients with arterial ..."
 
Vol 18, No 3 (2022) Aromatic Amino Acids: Phenylalanine and Tyrosine in Patients with Hypertension and Coronary Artery Disease Abstract  similar documents
A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov
"... low-density lipoproteins and AAA levels (Phe r=0,326 and Tyr r=0,365, p<0,05), while in patients ..."
 
Vol 8, No 4 (2012) EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS Abstract  similar documents
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze
"... Widespread use of antihypertensive and lipid-lowering agents in clinical practice determines ..."
 
Vol 20, No 5 (2024) Russian extreme hypertriglyceridemia registy (REGGI): a call to action Abstract  similar documents
U. V. Chubykina, M. V. Ezhov, A. A. Sokolov, P. A. Vasiluev, O. N. Ivanova, E. Y. Zakharova
"... data from patients with specific pathologies, and enable analysis of this data and the subsequent ..."
 
Vol 18, No 3 (2022) Assessment of the Quality of Drug Therapy in Patients with Stable Coronary Artery Disease in the Second Stage of the ALIGN Study Abstract  similar documents
E. D. Zharkova, S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, O. M. Drapkina
"... .002), lipid-lowering drugs (p=0.008) by patients was found during the second visit. The proportion of patients ..."
 
Vol 13, No 2 (2017) COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH Abstract  similar documents
O. M. Drapkina
"... with perindopril (as monotherapy or as a fixed combination with amlodipine or indapamide) together with lipid ..."
 
Vol 11, No 2 (2015) HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... be taken into consideration). 67% of patients had good adherence to lipid-lowering therapy 3.9 years after ..."
 
Vol 4, No 2 (2008) EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY Abstract  similar documents
A. V. Semenov, D. A. Sichev, V. G. Kukes
"... of lipid-lowering diet. Atorvastatin (80 mg once daily in the first treatment day) was given to patients ..."
 
Vol 15, No 1 (2019) How Does the Presence of Diabetes Affect the Course of Acute Coronary Syndrome in Elderly Patients in Actual Clinical Practice? Abstract  similar documents
M. R. Atabegashvili, E. V. Konstantinova, M. D. Muksinova, A. E. Udovichenko, A. P. Nesterov, M. O. Zheltoukhova, L. S. kyzy Muradova, M. Y. Gilarov
"... (p>0.05), age variance was 75-100 years. DM was found in 29% of all elderly patients ..."
 
Vol 13, No 5 (2017) IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? Abstract  similar documents
A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova
"... prescribed antihypertensive and lipid-lowering therapy, recommendations for a healthy lifestyle. In the main ..."
 
Vol 21, No 1 (2025) Cytokine profile of surgical patients with infective endocarditis Abstract  similar documents
E. O. Kotova, A. S. Pisaryuk, A. V. Lokhonina, A. Y. Moiseeva, E. A. Domonova, T. A. Gusarova, J. I. Babukhina, P. V. Kakhktsyan, T. K. Fatkhudinov, Z. D. Kobalava
"...    Aim. To study the cytokine profile of macrophages in valve tissues in operated patients ..."
 
Vol 21, No 2 (2025) Prognostic factors for stent restenosis in patients with coronary artery disease undergoing percutaneous coronary intervention Abstract  similar documents
M. А. Meshkova, I. A. Starodubtseva, A. A. Pashkova
"... as the achievement of target low-density lipoprotein cholesterol level with lipid-lowering therapy. Material ..."
 
Vol 16, No 1 (2020) Cross-Sectional Study to Estimate the Prevalence of Familial Hypercholesterolemia in Selected Regions of the Russian Federation: Relevance, Design of the Study and Initial Characteristics of the Participants Abstract  similar documents
A. N. Meshkov, A. I. Ershova, S. A. Shalnova, A. S. Alieva, S. S. Bazhan, O. L. Barbarash, D. Y. Bogdanov, I. A. Viktorova, Yu. I. Grinshtein, D. V. Duplyakov, O. N. Kalachikova, A. V. Kontsevaya, R. A. Libis, I. V. Medvedeva, V. A. Nevzorova, N. N. Prishchepa, O. P. Rotar, V. N. Serebryakova, I. A. Trubacheva, T. M. Chernykh, E. A. Shutemova, O. M. Drapkina, S. A. Boytsov
"... and duration of lipid-lowering therapy throughout life, presence and dates of secondary causes ..."
 
Vol 16, No 5 (2020) Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko
"... for the effectiveness of 3-month lipid-lowering therapy was a decrease in LDL-C level by 1 mmol/l. The median ..."
 
Vol 7, No 2 (2011) REPORT ON SCIENTIFIC AND EDUCATIONAL FORUM “CARDIOLOGY 2011”  similar documents
G. Ya. Maslennikova
 
Vol 8, No 5 (2012) EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov
"... patients with diabetes mellitus (DM) in accordance with target blood pressure (BP) <130/80 mm Hg ..."
 
Vol 7, No 5 (2011) ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva
"... and international normalized ratio (INR) control for patients with atrial fibrillation (AF) per 1 year of treatment ..."
 
Vol 11, No 1 (2015) MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT Abstract  similar documents
O. M. Drapkina, E. M. Chernova
"... Statins are lipid-lowering drugs with proven efficacy that reduce cardiovascular risk and are well ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... . Results. Controlled lipid-lowering therapy in combination with UDCA resulted in a significant reduction ..."
 
Vol 6, No 4 (2010) CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE Abstract  similar documents
O. I. Afanasieva, M. V. Ezhov, M. I. Afanasieva, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky
"... vascular area in 18-50% of patients. High serum level of lipoprotein(a) [Lp(a)] is an independent risk ..."
 
Vol 9, No 5 (2013) LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY Abstract  similar documents
O. I. Afanasieva, S. N. Pokrovsky
"... Antisense oligonucleotides (ASO) technology in elaboration of drugs for lipid metabolism ..."
 
1 - 100 of 1632 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)